Gynecologic Oncology: Recent Episodes
Various
This new series of monthly podcasts will feature information on a wealth of emerging topics in the field of Gynecological Oncology. Each month one of our Editor's will have an in-depth conversation with the Author of a Editor's Choice article as well as the Author of the commentary/editorial that accompanies the article. Gynecologic Oncology is devoted to the publication of clinical and investigative articles that concern tumors of the female reproductive tract and our hope is that these podcasts assist on this issue. Visit https://www.gynecologiconcology-online.net/podcasts to learn about the papers behind the podcasts.
Editor’s Choice Papers:
Improving genetic testing following abnormal mismatch repair immunohistochemistry results in endometrial cancer
Editorial: Universal testing – Should it be that hard? Probably. If you're doing it right
Hosted by:
Gregg Nelson, MD, PhD, Social Media Editor of Gynecologic Oncology
Featuring:
Bhavana Pothuri, MD,NYU Perlmutter Cancer Center
Leigha Senter, MS, CGC, The Ohio State University College of Medicine
Editor’s Choice Papers:
Detection of endometrial cancer using tampon-based collection and methylated DNA markers
Editorial: Early detection of endometrial cancer
Hosted by:
Dineo Khabele, MD, Associate Editor of Gynecologic Oncology
Featuring:
Jamie N. Bakkum-Gamez, MD, Mayo Clinic
Jonathan C. Dudley, MD, The Johns Hopkins University School of Medicine
TKI Toxicities: A Society of Gynecologic Oncology Podcast
Moderator:
Róisín O’Cearbhaill, MD, Gynecologic Medical Oncologist, Memorial Sloan Kettering Cancer Center, New York
Speakers:
BJ Rimel, MD, Gynecologic Oncologist, Cedars-Sinai Medical Center
Erin Crane, MD, MPH, Gynecologic Oncologist, Levine Cancer Institute
Vicky Makker, MD, Medical Oncologist, Memorial Sloan Kettering Cancer Center
Jennifer MacDonald, PharmD, Oncology Clinical Pharmacy Specialist, Medical University of South Carolina
Róisín O’Cearbhaill, MD, is joined by BJ Rimel, MD, Erin Crane, MD, MPH, Vicky Makker, MD, and Jennifer McDonald, PharmD, to review the clinical management of tyrosine kinase inhibitors (TKIs) in gynecologic cancers with consideration for dose adjustments and modifications. The speakers discuss the optimal management of commonly encountered toxicities, such as hypertension and hypothyroidism, that are associated with several of the TKIs.
They also highlight management strategies, patient reference materials and anticipatory prescriptions for antihypertensives, antidiarrheals, and antiemetics. The podcast includes two patient cases that delve into information about the differences in toxicities between lenvatinib and pazopanib, hypertension and which drugs to use in which order (both starting dose and dose adjustments), and medical access and lab intervals. These practical clinical pearls in managing toxicities aim to guide practitioners on how best to use these drugs to treat gynecologic cancers.
This podcast was developed by the Society of Gynecologic Oncology for Gynecologic Oncology.
Additional Resources: Tyrosine kinase inhibitor toxicities: A Society of Gynecologic Oncology review and recommendations
Download audio
Browse all Gynecologic Oncology audio
Moderator: Róisín O’Cearbhaill, MD, Gynecologic Medical Oncologist, Memorial Sloan Kettering Cancer Center, New York
Moderator: Kari Hacker, MD, PhD, Gynecologic Oncologist, New York University Langone Health
Hosted by: Gregg Nelson, MD, PhD, Social Media Editor of Gynecologic OncologyFeaturing:Brittany A. Davidson, MD, Duke University,David M. Kushner, MD, UW School of Medicine and Public HealthArticle: SGO and the elephant that is still in the room: Wellness, burnout and gynecologic oncology
Hosted by: Ursula Matulonis, MD, Associate Editor of Gynecologic Oncology and Author of the editorial
Moderator: Leslie Clark, MD, Gynecologic Oncologist, University of North Carolina in Chapel Hill
Moderator: Floor Backes, MD, Gynecologic Oncologist, The Ohio State University Comprehensive Cancer Center
Hosted by Barbara Goff: Deputy Editor, Gynecologic Oncology and Gynecologic Oncology Reports and Featuring Sabrina Ford & Sandra Brooks
Hosted by Dr. David E. Cohn, MD, MBA, President, Society of Gynecologic Oncology, Deputy Editor Gynecologic Oncology and Featuring Warner K. Huh, MD; Immediate Past-President, Society of Gynecologic Oncology
Hosted by Dr. Laurel Rice, Associate Editor and Featuring Dr. David Gershenson, Unveristy of Texas
Hosted by: Dr. Deborah K. Armstrong and Featuring: Dr. Eskander, Dr. O'Cearbhaill, Dr. Pothuri
Editor's Choice Paper: "Extensive financial hardship among gynecologic cancer patients starting a new line of therapy" and Editorial Paper: "Financial toxicity: An adverse effect worth of a black box warning?" Hosted by: Dr. Beth Karlan, Editor-In-Chief and Featuring: Dr. Karlan, Dr. Liang, Dr. Rauh-Hain
Editor's Choice Paper: "Genomic heterogeneity in peritoneal implants: A differential analysis of gene expression using nanostring Human Cancer Reference panel identifies a malignant signature" and Editorial Paper: "Not All Peritoneal Implants Are Created Equal" Hosted by: Dr. David Cohn, Deputy Editor and Featuring: Dr. Cohn, Dr. Fauceglia, Dr. Shih
Editor's Choice Paper: "A phase II randomized, double-blind trial of a polyvalent Vaccine-KLH conjugate (NSC 748933 IND# 14384) + OPT-821 versus OPT-821 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer who are in second or third complete remission: An NRG Oncology/GOG study" and Editorial Paper: "Sunset, or dawn of a new age for ovarian cancer vaccine therapy?" Hosted by: Dr. Barbara Goff, Deputy Editor and Featuring: Dr. O'Cearbhaill, Dr. Jazaeri, Dr. Goff
Editor's Choice Paper: "Role of lymphadenectomy in endometrial cancer with nonbulky lymph node metastasis: Comparison of comprehensive surgical staging and sentinel lymph node algorithm" and Editorial Paper: "Enough already: Is this the end of comprehensive lymphadenectomy in endometrial cancer or are further trials needed?" Hosted by: Dr. Stephen Rubin, Deputy Editor and Featuring: Dr. Rubin, Dr. Mariani, Dr. Fader
Editor's Choice Paper: "When to stop human chorionic gonadotrophin (hCG) surveillance after treatment with chemotherapy for gestational trophoblastic neoplasia (GTN): A national analysis on over 4,000 patients" and Editorial Paper: "Continued hCG surveillance following chemotherapy for gestational trophoblastic neoplasia: When is enough enough?" Hosted by: Dr. Beth Karlan, Editor-in-Chief and Featuring: Dr. Berkowitz, Dr. Karlan, Professor Seckl